#dryAMD

Simon J. Clark

@prof-clark.bsky.social

2 months ago

Ocugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas Ocugen has reported preliminary phase 2 data on its e | Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform…

Prelim Phase 2 data hint Ocugen’s AAV5 gene therapy (OCU410) may outperform approved GA treatments at mid-dose, while higher doses raise intriguing biology questions 👀🧬 #GeneTherapy #DryAMD #GeographicAtrophy #Biotech #ClinicalTrials

@longevitytech.bsky.social

5 months ago

Cirrus Therapeutics lands seed funding to advance gene therapy designed to prevent and reverse dry AMD by rejuvenating the retina.

longevity.technology/news/gene-th...

#longevity #aging #biotech #visionloss #dryAMD #genetherapy #investment

Hao Yin

@haoyin.bsky.social

5 months ago

#DryAMD #AgerelatedMacularDegeneration

Rat focal #ChoroidAtropy◀️NaIO3 into suprachoroidal space
⏬Choroid thickness
⏬vessel density/junctions

partial rescued by #hiPSC-#EndothelialCell transplant 7 dpi
👉making 30~40% of choroid vessels

#AdvSci 2025
advanced.onlinelibrary.wiley.com/doi/10.1002/...

Ophthalmic Professional

@ophthalmicpro.bsky.social

6 months ago

Mary Pat Johnson, COMT, CPC, COE, CPMA, Corcoran Consulting Group, discusses the procedure and the documentation, coding and coverage instructions for billing for Photobiomodulation (PBM). ow.ly/VEYa50WNWaW #Photobiomodulation #DryAMD #ophthalmology #eyecare

Simon J. Clark

@prof-clark.bsky.social

8 months ago

Alcon to buy LumiThera’s light-based therapy for dry AMD Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which obtained a groundbreaking FDA clearance late last year. | LumiThera's approach…

Alcon has acquired the Valeda photobiomodulation devise, using low-level light to help stimulate mitochondrial activity in the cells of the retina, marking a pivotal expansion into non-invasive therapies for early and intermediate dry AMD. #DryAMD

Ophthalmology Management

@ophthalmologymg.bsky.social

8 months ago

Alcon announced it will acquire LumiThera, Inc., a developer of photobiomodulation (PBM) therapy for dry AMD, in a move that broadens its retinal treatment portfolio beyond surgery. Learn more here: ow.ly/2MJR50WnyRO.
#dryAMD #Alcon #LumiThera #photobiomodulation #PBM

40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

8 months ago

First patient dosed in trial for novel dry AMD treatment PST-611 - PharmaTimes PulseSight begins phase 1 safety study of gene therapy for geographic atrophy

#Ophthalmology #clinicaltrial #dryAMDtreatment #PST611 #PulseSightTherapeutics #phase1safetystudy #genetherapy #geographicatrophy #GA #nonviralgenetherapy #dryagerelatedmaculardegeneration #AMD #DryAMD #PST611CT1study #electrotransfectiontechnology #DNAplasmids
pharmatimes.com/news/first-p...

@longevitytech.bsky.social

8 months ago

Could gene therapy trial halt vision loss?

#longevity #biotech #genetherapy #dryAMD #visionloss 

longevity.technology/news/pulsesi...

Consumer Watch (Deb)

@consumerwatch.bsky.social

9 months ago

NIH scientists test in an Animal Model a Surgical Technique to Improve Cell Therapy For Dry AMD 🔬 The Technique May Enable Higher Doses and Combinations of Cell Therapies. 👨‍🔬

Read Article
www.nih.gov/news-events/...

#NIH #HealthTips #Scientists #TEST #Animal #CellTherapy #DryAMD #AMD #CellHealth

Peter Bloomfield

@psbloom.bsky.social

10 months ago

Great to see a Phase II #trial of #oral treatment for Geographic Atrophy (late stage #dryAMD) 🧪💊 @boehringerglobal.bsky.social www.boehringer-ingelheim.com/science-inno...

Andrew Lloyd ALA

@andrewlloydala.bsky.social

1 year ago

💥[ALA Client News] Dry AMD: SeaBeLife achieves highly promising preclinical efficacy results for SBL03, without injections into eye

👉 ala.associates/clinical/dry...

#DryAMD #Ophthalmology #ClinicalTrial #Biotech